MDGL, Madrigal Pharmaceuticals, Inc

"Loading Stock Price & Valuation Data ..."

Agentic AI (Pro) Picks for MDGL

Subscribe to iPick.ai (Pro) to use Power Picks, Hidden-Gem Picks, and more.


News Summary: Subscribe

Unlock News Summary by Subscribing to iPick.ai Premium!





Unlock Ask MDGL by Subscribing to iPick.ai Premium!



Stock Chart




Latest YouTube Video:



CEO:Mr. William J. Sibold

Headquarter: Four Tower Bridge, 200 Barr Harbor Drive Suite 200, West Conshohocken, PA, United States, 19428

Industry: Biotechnology,   Investment Track: CNS autoimmune therapy,   Employees: 915

Business Summary

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.